Search research articles
Contact Us
Filters
Showing results (151-160 of 332) with videos related to
Page
of 34
Sort By:
Wiener Medizinische Wochenschrift (1946)
|
April 24, 2001
[Marine toxins]
A Lueger, D Scherr, B Lang, et al.
International Journal of Cardiology
|
October 2, 2001
Vascular endothelial growth factor expression in patients suffering from thrombangitis obliterans
M Brodmann, W Renner, G Stark, et al.
Clinical Therapeutics
|
March 9, 2010
Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study
Samuel W Boellner, Jeffrey G Stark, Suma Krishnan, et al.
VASA. Supplementum
|
January 1, 1989
[Effects of prostaglandin E1 on O2 utilization and vascular resistance. Results of experimental and clinical studies]
G Stark, U Stark, H Bertuch, et al.
VASA. Supplementum
|
January 1, 1988
[HLA antigen markers in patients with atherosclerosis]
H Bertuch, E Pilger, G Lanzer, et al.
Cell
|
March 11, 1994
A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells
S Hemmi, R Böhni, G Stark, et al.
The EMBO Journal
|
October 17, 1994
Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes
L F Reis, H Ruffner, G Stark, et al.
Journal of Child and Adolescent Psychopharmacology
|
September 22, 2017
Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
Carolyn R Sikes, Russ L McMahen, Jeffrey G Stark, et al.
Aesthetic Surgery Journal
|
August 21, 2018
A 3D Morphometrical Evaluation of Brow Position After Standardized Botulinum Toxin A Treatment of the Forehead and Glabella
Stefan Schlager, Jana Kostunov, Dominic Henn, et al.
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Cernilton for benign prostatic hyperplasia
T Wilt, R Mac Donald, A Ishani, et al.
Page
of 34
Search research articles
Search
Showing results (151-160 of 332) with videos related to
Sort By:
Page
of 34
Wiener Medizinische Wochenschrift (1946)
|
April 24, 2001
[Marine toxins]
A Lueger, D Scherr, B Lang, et al.
International Journal of Cardiology
|
October 2, 2001
Vascular endothelial growth factor expression in patients suffering from thrombangitis obliterans
M Brodmann, W Renner, G Stark, et al.
Clinical Therapeutics
|
March 9, 2010
Pharmacokinetics of lisdexamfetamine dimesylate and its active metabolite, d-amphetamine, with increasing oral doses of lisdexamfetamine dimesylate in children with attention-deficit/hyperactivity disorder: a single-dose, randomized, open-label, crossover study
Samuel W Boellner, Jeffrey G Stark, Suma Krishnan, et al.
VASA. Supplementum
|
January 1, 1989
[Effects of prostaglandin E1 on O2 utilization and vascular resistance. Results of experimental and clinical studies]
G Stark, U Stark, H Bertuch, et al.
VASA. Supplementum
|
January 1, 1988
[HLA antigen markers in patients with atherosclerosis]
H Bertuch, E Pilger, G Lanzer, et al.
Cell
|
March 11, 1994
A novel member of the interferon receptor family complements functionality of the murine interferon gamma receptor in human cells
S Hemmi, R Böhni, G Stark, et al.
The EMBO Journal
|
October 17, 1994
Mice devoid of interferon regulatory factor 1 (IRF-1) show normal expression of type I interferon genes
L F Reis, H Ruffner, G Stark, et al.
Journal of Child and Adolescent Psychopharmacology
|
September 22, 2017
Pharmacokinetics of a New Amphetamine Extended-Release Oral Suspension in Children with Attention-Deficit/Hyperactivity Disorder
Carolyn R Sikes, Russ L McMahen, Jeffrey G Stark, et al.
Aesthetic Surgery Journal
|
August 21, 2018
A 3D Morphometrical Evaluation of Brow Position After Standardized Botulinum Toxin A Treatment of the Forehead and Glabella
Stefan Schlager, Jana Kostunov, Dominic Henn, et al.
The Cochrane Database of Systematic Reviews
|
May 5, 2000
Cernilton for benign prostatic hyperplasia
T Wilt, R Mac Donald, A Ishani, et al.
Page
of 34